Mycophenolate mofetil

Effects on cellular immune subsets, infectious complications, and antimicrobial activity: Review article

M. L. Ritter, Liise-anne Pirofski

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Mycophenolate mofetil (MMF) is one of the most frequently used immunosuppressive drugs in solid organ transplant recipients. MMF is an inhibitor of inosine-5′-monophosphate, and is able to preferentially inhibit B-cell and T-cell function. The immunosuppressive abilities of MMF have made it one of the most successful anti-rejection drugs in transplant patients, but patients also appear to have increased susceptibility to infections, specifically cytomegalovirus and BK virus. Despite its association with an increased risk of infection, MMF has also exhibited antimicrobial activity against pathogens including hepatitis C, Pneumocystis jirovecii, and human immunodeficiency virus. A thorough understanding of the functions of MMF on the immune system and interaction with infectious pathogens could be helpful in implementing preventative strategies against opportunistic infections in transplant patients.

Original languageEnglish (US)
Pages (from-to)290-297
Number of pages8
JournalTransplant Infectious Disease
Volume11
Issue number4
DOIs
StatePublished - Aug 2009

Fingerprint

Mycophenolic Acid
Immunosuppressive Agents
Transplants
BK Virus
Pneumocystis carinii
Inosine Monophosphate
Opportunistic Infections
Cytomegalovirus Infections
Hepatitis C
Pharmaceutical Preparations
Immune System
B-Lymphocytes
HIV
T-Lymphocytes
Infection

Keywords

  • BK virus
  • Cytomegalovirus
  • Mycophenolate mofetil
  • Solid organ transplant

ASJC Scopus subject areas

  • Transplantation
  • Infectious Diseases

Cite this

@article{bc5bb572759c4a68916b334602777742,
title = "Mycophenolate mofetil: Effects on cellular immune subsets, infectious complications, and antimicrobial activity: Review article",
abstract = "Mycophenolate mofetil (MMF) is one of the most frequently used immunosuppressive drugs in solid organ transplant recipients. MMF is an inhibitor of inosine-5′-monophosphate, and is able to preferentially inhibit B-cell and T-cell function. The immunosuppressive abilities of MMF have made it one of the most successful anti-rejection drugs in transplant patients, but patients also appear to have increased susceptibility to infections, specifically cytomegalovirus and BK virus. Despite its association with an increased risk of infection, MMF has also exhibited antimicrobial activity against pathogens including hepatitis C, Pneumocystis jirovecii, and human immunodeficiency virus. A thorough understanding of the functions of MMF on the immune system and interaction with infectious pathogens could be helpful in implementing preventative strategies against opportunistic infections in transplant patients.",
keywords = "BK virus, Cytomegalovirus, Mycophenolate mofetil, Solid organ transplant",
author = "Ritter, {M. L.} and Liise-anne Pirofski",
year = "2009",
month = "8",
doi = "10.1111/j.1399-3062.2009.00407.x",
language = "English (US)",
volume = "11",
pages = "290--297",
journal = "Transplant Infectious Disease",
issn = "1398-2273",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Mycophenolate mofetil

T2 - Effects on cellular immune subsets, infectious complications, and antimicrobial activity: Review article

AU - Ritter, M. L.

AU - Pirofski, Liise-anne

PY - 2009/8

Y1 - 2009/8

N2 - Mycophenolate mofetil (MMF) is one of the most frequently used immunosuppressive drugs in solid organ transplant recipients. MMF is an inhibitor of inosine-5′-monophosphate, and is able to preferentially inhibit B-cell and T-cell function. The immunosuppressive abilities of MMF have made it one of the most successful anti-rejection drugs in transplant patients, but patients also appear to have increased susceptibility to infections, specifically cytomegalovirus and BK virus. Despite its association with an increased risk of infection, MMF has also exhibited antimicrobial activity against pathogens including hepatitis C, Pneumocystis jirovecii, and human immunodeficiency virus. A thorough understanding of the functions of MMF on the immune system and interaction with infectious pathogens could be helpful in implementing preventative strategies against opportunistic infections in transplant patients.

AB - Mycophenolate mofetil (MMF) is one of the most frequently used immunosuppressive drugs in solid organ transplant recipients. MMF is an inhibitor of inosine-5′-monophosphate, and is able to preferentially inhibit B-cell and T-cell function. The immunosuppressive abilities of MMF have made it one of the most successful anti-rejection drugs in transplant patients, but patients also appear to have increased susceptibility to infections, specifically cytomegalovirus and BK virus. Despite its association with an increased risk of infection, MMF has also exhibited antimicrobial activity against pathogens including hepatitis C, Pneumocystis jirovecii, and human immunodeficiency virus. A thorough understanding of the functions of MMF on the immune system and interaction with infectious pathogens could be helpful in implementing preventative strategies against opportunistic infections in transplant patients.

KW - BK virus

KW - Cytomegalovirus

KW - Mycophenolate mofetil

KW - Solid organ transplant

UR - http://www.scopus.com/inward/record.url?scp=68849105495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849105495&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3062.2009.00407.x

DO - 10.1111/j.1399-3062.2009.00407.x

M3 - Article

VL - 11

SP - 290

EP - 297

JO - Transplant Infectious Disease

JF - Transplant Infectious Disease

SN - 1398-2273

IS - 4

ER -